SoftMining Academic Foundry

Fund the experiments.
Build the asset.
Share the value

A selective pathway for academic drug-discovery projects that need funding, international collaboration and decisive preclinical validation.

The win–win structure

No upfront fee. Compensation only after funding.

€0 upfront8% if funded

The initial assessment and grant preparation start at no cost. An 8% fee applies only to funding obtained; the calculation basis, debtor and payment terms are agreed in writing.

Case by case≤50%

For post-validation development, SoftMining’s share in the new asset is negotiated case by case according to its role and never exceeds 50%, subject to the project agreement.

The academic validation gap

Excellent science often stops one experiment too early

A result may be publishable and scientifically important without yet being investable, licensable or ready for pharmaceutical development.

From academic result to validated asset

The Foundry pathway

Each stage creates value before the next begins

Projects start non-confidentially. Only scientifically strong and fundable opportunities proceed to deeper review, consortium construction and funded validation.

01

Submit the academic result

The researcher provides a concise non-confidential description of the discovery, existing evidence, unmet need and validation gap.

02

Assess scientific quality and fundability

ADAPT evaluates robustness, translational potential, validation needs, development feasibility and grant readiness.

03

Build the funding strategy

If the project passes the threshold, SoftMining identifies the most suitable call, assembles the international consortium and prepares the application.

04

Complete funded validation

The funded programme performs the decisive biological, mechanistic, DMPK, safety, formulation or preclinical studies agreed for the project.

05

Create a shared pharmaceutical asset

When predefined validation criteria are met, the academic contribution and SoftMining’s development contribution are recognised in the exploitation model.

Foundry infrastructure

Assessment, consortium building and grant execution in one programme

These tools belong to the Academic Foundry pathway and are used together only after the scientific project passes the initial threshold.

IM

InnoMatch

Identifies complementary international partners and builds the consortium.

FA

FundingAgent

Matches the scientific project with the most suitable competitive funding opportunities.

GC

GrantCompiler

Structures and prepares the submission using project, call and consortium data.

Transparent economics

Funding first. Shared value after validation

Academic teams can begin without an upfront fee. SoftMining is compensated only when funding is secured; any share in a new asset is negotiated after validation.

When the grant is funded

€0 upfront
8% only if funded

€0 upfront8% if funded

The fee applies only to funding obtained. Its calculation basis, debtor and payment terms are agreed in writing. The fee is not automatically eligible as a grant cost.

After successful validation

Negotiated case by case
Never above 50%

Project holdersSoftMining ≤50%

Based on SoftMining’s role, any share in the new asset is negotiated case by case and never exceeds 50%. Ownership, exploitation and licensing terms remain subject to predefined scientific criteria and signed institutional agreements.

Clear rules from the beginning

Scientific independence and commercial logic can coexist

Submission is not an assignment. Rights, milestones and responsibilities become operative only through the relevant institutional and project agreements.

01 / INTAKE

No automatic IP transfer

Initial submission and ADAPT assessment do not, by themselves, transfer rights to SoftMining.

02 / REVIEW

Confidentiality when required

Projects begin with non-confidential information and move to NDA-protected review when appropriate.

03 / VALIDATION

Predefined success criteria

Scientific milestones, contributions, budgets and decision gates are agreed before funded work begins.

04 / VALUE

Transparent exploitation terms

Background IP, publication, licensing and rights in validated Project Molecules are defined contractually.

What the Foundry selects

Strong science with a decisive, fundable validation path

Selection is intentionally selective. SoftMining advances projects where its platform, funding intelligence and development capability can materially change the trajectory.

01Scientific robustness and reproducibility
02Meaningful unmet need and translational relevance
03Experiments capable of changing asset value
04Researcher and institution ready to collaborate

Start non-confidentially

Your research may already contain the basis of a fundable programme

Send a concise description of the scientific result, supporting evidence, unmet need and the experiment that would most change the project’s value.

01

What you discovered

target · molecule · mechanism

02

What supports it

experiments · publications · data

03

What is missing

validation · funding · partners